Alkermes

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Alkermes and other ETFs, options, and stocks.

About ALKS

Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL. 

CEO
Blair C. Jackson
CEOBlair C. Jackson
Employees
2,050
Employees2,050
Headquarters
Dublin, Dublin
HeadquartersDublin, Dublin
Founded
2011
Founded2011
Employees
2,050
Employees2,050

ALKS Key Statistics

Market cap
8.11B
Market cap8.11B
Price-Earnings ratio
125.53
Price-Earnings ratio125.53
Dividend yield
Dividend yield
Average volume
1.29M
Average volume1.29M
High today
$48.67
High today$48.67
Low today
$47.33
Low today$47.33
Open price
$48.07
Open price$48.07
Volume
861.09K
Volume861.09K
52 Week high
$55.67
52 Week high$55.67
52 Week low
$25.17
52 Week low$25.17

Stock Snapshot

Alkermes(ALKS) stock is priced at $48.33, giving the company a market capitalization of 8.11B. It carries a P/E multiple of 125.53.

As of 2026-08-23, Alkermes(ALKS) stock has fluctuated between $47.33 and $48.67. The current price stands at $48.33, placing the stock +2.1% above today's low and -0.7% off the high.

Alkermes(ALKS) shares are trading with a volume of 861.09K, against a daily average of 1.29M.

In the last year, Alkermes(ALKS) shares hit a 52-week high of $55.67 and a 52-week low of $25.17.

In the last year, Alkermes(ALKS) shares hit a 52-week high of $55.67 and a 52-week low of $25.17.

ALKS News

Simply Wall St 3d
Alkermes Cuts Loan Costs, Is The 10% Undervalued View Convincing?

Alkermes (ALKS) drew investor attention after amending its February 2026 credit agreement, reducing interest rate spreads on its senior secured term loan A and...

Alkermes Cuts Loan Costs, Is The 10% Undervalued View Convincing?

Analyst ratings

71%

of 17 ratings
Buy
70.6%
Hold
23.5%
Sell
5.9%

People also own

Based on the portfolios of people who own ALKS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.